Centro de Referencia para Lactobacilos (CERELA-CONICET), San Miguel de Tucumán, Argentina.
Cátedra de Inmunología. Facultad de Bioquímica, Química y Farmacia, Universidad Nacional de Tucumán, San Miguel de Tucumán, Argentina.
Ann Nutr Metab. 2019;74(2):115-124. doi: 10.1159/000496426. Epub 2019 Jan 23.
BACKGROUND: The gastrointestinal tract is one of the most microbiologically active ecosystems that plays a crucial role in the working of the mucosal immune system (MIS). In this ecosystem, the consumed probiotics stimulate the immune system and induce a network of signals mediated by the whole bacteria or their cell wall structure. This review is aimed at describing the immunological mechanisms of probiotics and their beneficial effects on the host. SUMMARY: Once administered, oral probiotic bacteria interact with the intestinal epithelial cells (IECs) or immune cells associated with the lamina propria, through Toll-like receptors, and induce the production of different cytokines or chemokines. Macrophage chemoattractant protein 1, produced by the IECs, sends signals to other immune cells leading to the activation of the MIS, characterized by an increase in immunoglobulin A+ cells of the intestine, bronchus and mammary glands, and the activation of T cells. Specifically, probiotics activate regulatory T cells that release IL-10. Interestingly, probiotics reinforce the intestinal barrier by an increase of the mucins, the tight junction proteins and the Goblet and Paneth cells. Another proposed mechanism of probiotics is the modulation of intestinal microbiota by maintaining the balance and suppressing the growth of potential pathogenic bacteria in the gut. Furthermore, it has been demonstrated that long-term probiotics consumption does not affect the intestinal homeostasis. The viability of probiotics is crucial in the interaction with IECs and macrophages favoring, mainly, the innate immune response. Macrophages and Dendritic cells (DCs) play an important role in this immune response without inducing an inflammatory pattern, just a slight increase in the cellularity of the lamina propria. Besides, as part of the machinery that probiotics activate to protect against different pathogens, an increase in the microbicidal activity of peritoneal and spleen macrophages has been reported. In malnutrition models, such as undernourishment and obesity, probiotic was able to increase the intestinal and systemic immune response. Furthermore, probiotics contribute to recover the histology of both the intestine and the thymus damaged in these conditions. Probiotic bacteria are emerging as a safe and natural strategy for allergy prevention and treatment. Different mechanisms such as the generation of cytokines from activated pro-T-helper type 1, which favor the production of IgG instead of IgE, have been proposed. Key Messages: Probiotic bacteria, their cell walls or probiotic fermented milk have significant effects on the functionality of the mucosal and systemic immune systems through the activation of multiple immune mechanisms.
背景:胃肠道是微生物学上最活跃的生态系统之一,在黏膜免疫系统(MIS)的运作中起着至关重要的作用。在这个生态系统中,摄入的益生菌会刺激免疫系统,并诱导由整个细菌或其细胞壁结构介导的信号网络。本综述旨在描述益生菌的免疫机制及其对宿主的有益影响。
摘要:口服益生菌进入人体后,通过 Toll 样受体与肠道上皮细胞(IECs)或固有层相关的免疫细胞相互作用,诱导产生不同的细胞因子或趋化因子。IECs 产生的巨噬细胞趋化蛋白 1 向其他免疫细胞发送信号,导致 MIS 激活,其特征是肠道、支气管和乳腺的免疫球蛋白 A+细胞增加,T 细胞激活。具体来说,益生菌会激活调节性 T 细胞,释放白细胞介素 10。有趣的是,益生菌通过增加粘蛋白、紧密连接蛋白以及杯状细胞和潘氏细胞来增强肠道屏障。益生菌的另一个作用机制是通过维持肠道菌群平衡和抑制肠道中潜在致病菌的生长来调节肠道菌群。此外,研究表明长期使用益生菌不会影响肠道内环境的稳定。益生菌的生存能力在与 IECs 和巨噬细胞相互作用中至关重要,这主要有利于先天免疫反应。巨噬细胞和树突状细胞(DCs)在这种免疫反应中发挥重要作用,而不会引起炎症模式,只是固有层细胞数量略有增加。此外,作为益生菌激活的机制的一部分,已报道腹腔和脾脏巨噬细胞的杀菌活性增加。在营养不良模型中,如营养不良和肥胖症,益生菌能够增加肠道和全身免疫反应。此外,益生菌有助于恢复这些条件下受损的肠道和胸腺组织学。益生菌作为预防和治疗过敏的一种安全、自然的策略正在出现。已经提出了不同的机制,例如从激活的辅助性 T 细胞 1 产生细胞因子,有利于 IgG 的产生而不是 IgE 的产生。
关键信息:益生菌细菌、它们的细胞壁或益生菌发酵乳对黏膜和全身免疫系统的功能有显著影响,通过激活多种免疫机制。
Ann Nutr Metab. 2019-1-23
Crit Rev Food Sci Nutr. 2016-12-9
Front Cell Infect Microbiol. 2017-5-5
J Cell Physiol. 2018-10-14
Front Med (Lausanne). 2025-8-1
Probiotics Antimicrob Proteins. 2025-6-2